All
Results: 53569-53580 of 54277

MoEngage Named A Leader in IDC MarketScape: Worldwide Omni-Channel Marketing Platforms for B2C Enterprises 2023

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China

AI TECHNOLOGY COMES TO PROPERTY VALUATIONS HOMEMOVE LAUNCHES "HOMER" AI TOOL TO FIND OUT WHAT HOUSES ARE REALLY WORTH
